An inhaled insulin drug proves hard for diabetics to get

Cynthia Goldstein demonstrates how to use the new inhalable insulin drug that helps treat her diabetes. Photo: TNS

It took 10 years and US$1bil (RM3.77bil) for MannKind Corp to get its breakthrough inhaled-insulin drug approved by US regulators.

Now comes the hard part: getting people with diabetes to use it.

Get 30% off with our ads free Premium Plan!

~~RM13.90/month~~
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

~~RM12.33/month~~
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

Free Trial

For new subscribers only

Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.

Report it to us.

What is the issue about?

Spelling and grammatical error

Factually incorrect

Story is irrelevant

Email (optional)